Infection control or infection prevention can be described as the procedures dealing with with handling of infections from a healthcare point of view. Infection control policy is a largely underrated system within the healthcare infrastructure and is only gradually gaining importance in recent years. Infection control procedures are largely implemented within various medical care systems rather in the real-world environment. The prevention and control of infection in a hospital or a healthcare centre falls under the purview of the Infection Prevention & Control Market. Thus, the market is well-positioned to register significant growth during the forecast period of 2016-2022.
Scope & Regional Forecast of the Infection Prevention & Control Market
The Infection Prevention & Control Market is expected to exhibit a CAGR of 5.3% during the forecast period due to a variety of reasons like: rise in awareness (& fear) among the general public after the recent massive Ebola outbreak in Africa; a growth in the population of the elderly whose weaker immune systems require vigilant infection protection; the rise of superbugs which are resistant all known antibiotics; and a demand for emerging countries for proper infection control training and infection prevention measures for the benefit of their medical personnel while dealing with hospital infections.
So far, the Infection Prevention & Control Market has dominated by demand emanating from North America, succeeded by Europe. The reasons for this dominant market share are rising awareness among public as well as medical care centres, a rise in reports of chronic diseases, and more instances of hospital acquired infections being noted. Constantly evolving lifestyles as well as helpful government initiatives like Obamacare have also boosted infection protection protocols. Meanwhile, Asia-Pacific is predicted to register the highest growth during the forecast period as emerging countries like China and India are eager to tackle and revamp their respective average healthcare infrastructure facilties.
Avail Sample @ http://industryarc.com/pdfdownload.php?id=1309
Segmentations & Key Players Involved in the Infection Prevention & Control Market
The Infection Prevention & Control Market can be broken down into various segmentations on the basis of –
Infection: Microbial Infections (Bacterial, Viral, Fungal) and Healthcare Associated Infection (Hospital Acquired, Community Acquired).
Anti-Microbial Drugs: Anti-Bacterial Drugs, Anti-Viral Drugs, Anti-Fungal Drugs and Vaccines.
Accessories & Equipment: Personal Protective Equipment (Gloves, Surgical Masks & Respirators, Surgical Drapes & Gown, Surgical Foot Covers, Medical Safety Glasses, Others), Disinfectants (Hand Sanitizers, Disinfectant Wipes, Surface Disinfectants, Instrument Disinfectants, Surgical Disinfectants, Environmental Disinfectants, Others) and Sterilization (Medical Device Sterilization Equipment, Dry Heat Sterilization and Low Temperature Sterilization).
End User Industry: End Users: Equipment Usage (Hospitals & Clinics, Medical laboratories, Manufacturing Units) and By Drug Usage (Individuals & Patients, Nursing & Senior care Centers).
Geographical Location: North America, Europe, Asia-Pacific and Rest of the World.
Some of the key players involved in the Infection Prevention & Control Market are as follows:
Why buy this report?
* The overall market has been consolidated from the perspective of different geographic locations and key economies for this market.
* Identifies growth sectors and factors driving or constraining the market.
* The market is analyzed based on the key attributes such as the power in the hands of producers and consumers, analysis on the degree of competition, and threats from substitutes and new entrants.
* The study includes the demand of this particular market on a global and regional scale for a six year period of 2016 – 2022, to assess how the market will develop.
Make an Inquiry @ http://industryarc.com/inquiry-before-buying.php?id=1309
Company Name: IndustryARC
Contact Person: Mr. Sanjay Matthews
Phone: 1-614-588-8538 (Ext: 101)
Country: United States